EQUITY RESEARCH MEMO
LeMaitre Vascular (LMAT)
Generated 4/27/2026
Executive Summary
Conviction (model self-assessment)75/100
LeMaitre Vascular is a global medical device company dedicated to developing and commercializing innovative solutions for peripheral vascular disease (PVD). Founded by a vascular surgeon, the company holds a strong legacy in valvulotomes and offers a broad portfolio of devices for arterial reconstruction, biologics, and endovascular procedures. With a focus on niche markets and a direct sales force, LeMaitre has consistently delivered revenue growth and profitability, benefiting from the aging population and increasing prevalence of PVD. The company's disciplined R&D strategy and selective acquisitions have bolstered its product offerings, while its strong balance sheet supports continued investment in innovation.
Upcoming Catalysts (preview)
- TBDFDA clearance of next-generation valvulotome70% success
- Q2 2026Expansion of sales force into new international markets65% success
- Q4 2026Positive clinical data for biologic patch product60% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)